371 related articles for article (PubMed ID: 18723841)
21. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
22. Cannabis and Psychosis Through the Lens of DSM-5.
Pearson NT; Berry JH
Int J Environ Res Public Health; 2019 Oct; 16(21):. PubMed ID: 31661851
[TBL] [Abstract][Full Text] [Related]
23. Gene-environment interactions underlying the effect of cannabis in first episode psychosis.
Pelayo-Terán JM; Suárez-Pinilla P; Chadi N; Crespo-Facorro B
Curr Pharm Des; 2012; 18(32):5024-35. PubMed ID: 22716151
[TBL] [Abstract][Full Text] [Related]
24. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
[TBL] [Abstract][Full Text] [Related]
25. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
Nieman DH; Dragt S; van Duin EDA; Denneman N; Overbeek JM; de Haan L; Rietdijk J; Ising HK; Klaassen RMC; van Amelsvoort T; Wunderink L; van der Gaag M; Linszen DH
Schizophr Res; 2016 Jul; 174(1-3):24-28. PubMed ID: 27052366
[TBL] [Abstract][Full Text] [Related]
26. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Psychopharmacology (Berl); 2016 Mar; 233(5):809-21. PubMed ID: 26621349
[TBL] [Abstract][Full Text] [Related]
28. The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val¹⁵⁸Met polymorphism.
Vinkers CH; Van Gastel WA; Schubart CD; Van Eijk KR; Luykx JJ; Van Winkel R; Joëls M; Ophoff RA; Boks MP; ; Bruggeman R; Cahn W; de Haan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
Schizophr Res; 2013 Oct; 150(1):303-11. PubMed ID: 23954148
[TBL] [Abstract][Full Text] [Related]
29. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
[TBL] [Abstract][Full Text] [Related]
30. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
31. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
32. Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms.
Carvalho C; Vieira-Coelho MA
Pharmacol Res; 2022 Jul; 181():106258. PubMed ID: 35588917
[TBL] [Abstract][Full Text] [Related]
33. Cannabis use and psychosis: theme introduction.
Martinotti G; Di Iorio G; Sepede G; De Berardis D; De Risio L; Di Giannantonio M
Curr Pharm Des; 2012; 18(32):4991-8. PubMed ID: 22716149
[TBL] [Abstract][Full Text] [Related]
34. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
35. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
[TBL] [Abstract][Full Text] [Related]
36. Drawing conclusions about cannabis and psychosis.
Castle D
Psychol Med; 2008 Mar; 38(3):459-60; author reply 462-4. PubMed ID: 18298876
[No Abstract] [Full Text] [Related]
37. Interpreting the association between cannabis use and increased risk for schizophrenia.
Weiser M; Noy S
Dialogues Clin Neurosci; 2005; 7(1):81-5. PubMed ID: 16060598
[TBL] [Abstract][Full Text] [Related]
38. Cannabis consumption and psychosis or schizophrenia development.
Ortiz-Medina MB; Perea M; Torales J; Ventriglio A; Vitrani G; Aguilar L; Roncero C
Int J Soc Psychiatry; 2018 Nov; 64(7):690-704. PubMed ID: 30442059
[TBL] [Abstract][Full Text] [Related]
39. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
40. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
